Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days
- PMID: 12069181
- DOI: 10.1097/00024382-200206000-00004
Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days
Abstract
Virtually of the all recent therapeutic interventions for treating sepsis have failed to improve survival. One potential explanation is that the heterogeneity of the immune response to the septic challenge is such that only a portion of the patients die as a result of excessive inflammation. The clinical trials lacked power because traditional measurements do not accurately identify these patients. Previous work has shown that higher levels of interleukin (IL)-6 are found in those mice that die from septic peritonitis; therefore, we sought to determine whether IL-6 measured 6 h after surgery could predict outcome. Adult, female BALB/c mice (n = 79) were subjected to cecal ligation and puncture with a 21-gauge needle and treated with imipenem in D5W every 12 h for 5 days, resulting in a homogenous population at the outset. Six hours after surgery, 20 microL of blood was obtained from the tail vein to measure IL-6. Mortality was followed for 21 days. Overall 3-day survival was 77%, and 21-day mortality was 56%. Plasma IL-6 levels >2,000 pg/mL were determined to predict mortality within the first 3 days with a sensitivity of 58% and specificity of 97%. To further refine the mortality prediction, body weight and a complete blood count were performed 24 hours after cecal ligation and puncture. Discriminate analysis indicated that a weighted formula combining body mass, lymphocyte, and platelet count would predict death with sensitivity of 83% and a specificity of 79%. We tested the value of the IL-6 prediction by surgically resecting the cecum in those animals with IL-6 > 2000 pg/mL, which resulted in a significant improvement in survival. These data demonstrate that IL-6 measured 6 h after injury accurately predicts mortality resulting from experimental sepsis. This measurement may be determined quickly so that therapy may be targeted only to those individuals at significant risk of dying and initiated within sufficient time to be effective.
Similar articles
-
Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels.Shock. 2004 Feb;21(2):121-5. doi: 10.1097/01.shk.0000108399.56565.e7. Shock. 2004. PMID: 14752284
-
Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.Crit Care Med. 2001 Mar;29(3):473-81. doi: 10.1097/00003246-200103000-00001. Crit Care Med. 2001. PMID: 11373406
-
Role of interleukin-6 in mortality from and physiologic response to sepsis.Infect Immun. 2005 May;73(5):2751-7. doi: 10.1128/IAI.73.5.2751-2757.2005. Infect Immun. 2005. PMID: 15845478 Free PMC article.
-
Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP mice.J Thromb Haemost. 2014 Jun;12(6):958-69. doi: 10.1111/jth.12565. J Thromb Haemost. 2014. PMID: 24655755
-
Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.Shock. 2000 Feb;13(2):110-6. doi: 10.1097/00024382-200013020-00004. Shock. 2000. PMID: 10670840
Cited by
-
Low-dose plasmid DNA treatment increases plasma vasopressin and regulates blood pressure in experimental endotoxemia.BMC Immunol. 2012 Nov 8;13:59. doi: 10.1186/1471-2172-13-59. BMC Immunol. 2012. PMID: 23137350 Free PMC article.
-
Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell Responses.Front Immunol. 2018 Oct 31;9:2532. doi: 10.3389/fimmu.2018.02532. eCollection 2018. Front Immunol. 2018. PMID: 30429857 Free PMC article.
-
Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.Infect Immun. 2010 Nov;78(11):4714-22. doi: 10.1128/IAI.00456-10. Epub 2010 Sep 7. Infect Immun. 2010. PMID: 20823197 Free PMC article.
-
The activity of the aryl hydrocarbon receptor in T cells tunes the gut microenvironment to sustain autoimmunity and neuroinflammation.PLoS Biol. 2023 Feb 14;21(2):e3002000. doi: 10.1371/journal.pbio.3002000. eCollection 2023 Feb. PLoS Biol. 2023. PMID: 36787309 Free PMC article.
-
Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats.Intensive Care Med. 2009 Aug;35(8):1471-8. doi: 10.1007/s00134-009-1545-x. Epub 2009 Jun 16. Intensive Care Med. 2009. PMID: 19529910
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical